{"cik":"0001962011","ticker":"KAPA","name":"Kairos Pharma, LTD.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"NYSE","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-13","last_filing_date":"2026-07-22","url":"/sec/cik-0001962011","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001493152-26-034185","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-22","title":"8-K — Kairos Pharma, LTD. — 2026-07-22","url_slug":"/sec/cik-0001962011/8-k/0001493152-26-034185","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-034185-index.html"},{"accession_number":"0001493152-26-033289","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-15","title":"8-K — Kairos Pharma, LTD. — 2026-07-15","url_slug":"/sec/cik-0001962011/8-k/0001493152-26-033289","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-033289-index.html"},{"accession_number":"0001493152-26-031328","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-30","title":"8-K — Kairos Pharma, LTD. — 2026-06-30","url_slug":"/sec/cik-0001962011/8-k/0001493152-26-031328","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-031328-index.html"},{"accession_number":"0001493152-26-027200","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-04","title":"8-K — Kairos Pharma, LTD. — 2026-06-04","url_slug":"/sec/cik-0001962011/8-k/0001493152-26-027200","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-027200-index.html"},{"accession_number":"0001493152-26-024082","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-18","title":"8-K — Kairos Pharma, LTD. — 2026-05-18","url_slug":"/sec/cik-0001962011/8-k/0001493152-26-024082","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-024082-index.html"},{"accession_number":"0001493152-26-022796","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-13","title":"10-Q — Kairos Pharma, LTD. — 2026-05-13","url_slug":"/sec/cik-0001962011/10-q/0001493152-26-022796","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-022796-index.html"}],"related_endpoints":{"profile":"/sec/KAPA/profile","timeline":"/sec/KAPA/timeline","peers":"/sec/KAPA/peers","insider_pulse":"/sec/KAPA/insider-pulse","insider_summary":"/sec/KAPA/insider-summary","insider_transactions":"/sec/KAPA/insider-transactions","form144":"/sec/KAPA/form144","holdings_as_filer":"/sec/KAPA/holdings","financial_facts":"/sec/KAPA/financial-facts","derivatives":"/sec/KAPA/derivatives","officers":"/sec/KAPA/officers","insider_network":"/sec/KAPA/insider-network","risk_flags":"/sec/KAPA/risk-flags","filings":"/sec/KAPA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=KAPA"}}